Technology Transition

DARPA launched the Revolutionizing Prosthetics program with a radical goal: gain U.S. Food and Drug Administration (FDA) approval for an advanced electromechanical prosthetic upper limb with near-natural control that enhances independence and improves quality of life for amputees. Today, less than eight years after the effort was launched, that dream is a reality; the FDA approved the DEKA Arm System.

DARPA has invested more than $200 million in support of President Obama's Brain Initiative since 2014. This Federal investment has accelerated the development of innovative neurotechnologies with the potential to improve human health and change the way people live, work, and play. On March 2, 2016, DARPA will host a small meeting of technology-minded investors, scientists, and entrepreneurs to showcase several current, cutting-edge neurotechnology efforts, consider future trajectories and potential applications, and encourage continued investment and eventual commercialization of some of these technologies. Space is limited. Interested parties with venture portfolios in this domain should email justin.sanchez@darpa.mil for more information and registration details.